Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares

Article content

TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) — Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 2,666,667 common shares (the “Common Shares”) at a price to the public of US$7.50 per Common Share, led by healthcare focused institutional investors. Gross proceeds to the Company from the Offering are expected to be approximately US$20,000,000, prior to deducting underwriting discounts and commissions and other expenses related to the Offering, assuming no exercise of the underwriter’s over-allotment option.